JANE KAPUSTIN: Open Payments
NPI 1114921681 · CLARKSVILLE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$11,690 in 53 payments from 16 companies in 2025. Trend: 2023 $9,867 · 2024 $7,825 · 2025 $11,690
Speaker / faculty: $5,710Consulting: $3,740Food & beverage: $1,765Travel & lodging: $443Education: $32
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 12 | $4,751 |
| CeQur Corporation | 2 | $3,944 |
| SANOFI-AVENTIS U.S. LLC | 4 | $1,896 |
| Novo Nordisk Inc | 8 | $290 |
| Corcept Therapeutics | 5 | $165 |
| Xeris Pharmaceuticals, Inc. | 6 | $149 |
| BETA BIONICS, INC. | 1 | $119 |
| Lilly USA, LLC | 5 | $105 |
| Tandem Diabetes Care, Inc. | 2 | $102 |
| Sequel Med Tech, LLC | 2 | $39 |
Products named: REZDIFFRA, CeQur Simplicity, TZIELD, Ozempic, Korlym, RECORLEV, iLet Bionic Pancreas, t:slim X2 Insulin Pump with Control-IQ.
Industry payments across MD — which companies pay providers there.
